CD7-CAR-T Cells
/ Hebei Taihe Chunyu Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
August 07, 2025
Clinical Study of the Safety and Efficacy of ASCT Combined With CD7-CART in the Treatment of CD7+ TCL
(clinicaltrials.gov)
- P2 | N=50 | Recruiting | Sponsor: Institute of Hematology & Blood Diseases Hospital, China
New P2 trial • Bone Marrow Transplantation • Hematological Malignancies • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology • T Cell Non-Hodgkin Lymphoma • Transplantation • CD7
August 18, 2025
CD7 CAR-T Combined With Autologous Hematopoietic Stem Cell Transplantation
(clinicaltrials.gov)
- P1/2 | N=38 | Not yet recruiting | Sponsor: Zhengzhou University
New P1/2 trial • Bone Marrow Transplantation • Hematological Malignancies • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology • T Cell Non-Hodgkin Lymphoma • Transplantation • CD7
June 06, 2025
CD7 CAR-T Cell Therapy Targeting CD7-positive Relapsed/Refractory T Cell Lymphoma/Acute Leukemia
(clinicaltrials.gov)
- P=N/A | N=40 | Not yet recruiting | Sponsor: Qi deng
New trial • Hematological Malignancies • Leukemia • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology • T Cell Non-Hodgkin Lymphoma • CD7
1 to 3
Of
3
Go to page
1